References
- Tee1 D W., Klein J O., Rasner B A. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 1980; 89(Suppl 68)5–6
- Tos M. Epidemiology and spontaneous improvement of secretory otitis Acta Otolaryngol (Belg) 1983; 37: 31–43
- DeMaria T F., Brigges B R., Lim D J., et al. Experimental otitis media with effusion following middle ear inocuration of nonviable H. influenzae. Ann Otol Rhinol Laryngol 1984; 93: 52–6
- Lim D J., DeMaria T F. Pathogenesis of otitis media: Bacteriology and immunology. Laryngoscope 1982; 92: 278–86
- Bernstein J M. Observation of immune mechanisms in otitis media with effusion. Int J Pediatr Otorhinolaryn‐go1 1986; 8: 125–38
- Bernstein J M. Recent advance in otitis media with effusion. Anal Allerg 1985; 55: 544–51
- Chonmaritree T, Howie V M. Bacteriology of otitis media. Immunology of the ear, J Bernstein, P Ogra. Raven Press, New York 1987; 231–47
- Mravec J, Lewis D W., Lim D J. Experimental otitis media. An immune complex mediated response. Otolaryngology 1978; 88: 258–68
- Hotomi M, Tabata T, Kakiuchi H, et al. Detection of Haemophilus influenzae in middle ear of otitis media with effusion. Int J Pediatr Otorhinolaryngol 1993; 27: 119–26
- Giebink G A., Carlson B A., Hetherington S V., et al. Bacteriae and polynuclear leukocyto contribution to middle ear inflammation in chronic otitis media with effusion. Ann Otol Rhinol Laryngol 1985; 94: 398–402
- Palva T, Lehitinen T, Virtanen H. Immune complex in the middle ear fluid and adenoid tissue in chronic secretory otitis media. Acta Otorlaryngol (Stockh) 1983; 95: 539–43
- Yellon R, Leonard G, Marucha P, et al. Characterization of cytokines present in middle ear effusion. Laryngoscope 1991; 101: 165–9
- Yellon R, Leonard G, Marucha P, et al. Demonstration of interleukin 6 in middle ear effusions. Arch Otolaryngol 1992; 118: 745–8
- Matsushima K, Morishima K, Yoshimura N, et al. Molecular cloning of a human monocyte‐derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and the tumor necrosis factor. J Exp Med 1988; 167: 1883–93
- Schroeder J M., Mowietz U, Morita E, et al. Purification and partial biochemical characterisation of a human monocyte‐derived neutrophil‐activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474–83
- Peveri P, Waltz A, Dewald B, et al. A novel neutrophil activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547–59
- Furuta R, Yamaguchi J, Kotani H, et al. Production and characterization of recombinant human neutrophil chemotaxic factor. J. Biochem 1989; 106: 436–42
- Van Damme J, Van Beeuman J, Opdenakke G, et al. A novel NH2‐terminal sequence‐characterised human monokine possessing neutrophil chemotactic skin‐reactive and granurocytosis promoting activity. J Exp Med 1988; 167: 1364–76
- Matsushima K, Oppemheim J J. Interleukin 8 and MCFA: a novel inflammatory cytokines induced by IL‐1 and TNF. Cytokine 1989; 1: 2–13
- Ko Y C., Mukaida N, Panyutich A, et al. A sensitive enzyme‐linked immunosorbent assay for human inter‐leukin‐8. J Immunol Meth 1992; 149: 227–35
- Rampart M, Herman A G., Grillet B, et al. Development and application of a radioimmunoassay for inter‐leukin 8: detection of interleukin 8 in synovial fluid from patients with inflammatory joint disease. Lab Invest 1992; 66: 512–8
- Brennan F M., Zacharie C O C, Chantry D, et al. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. J Immunol 1990; 20: 2141–4
- Symons J A., Wong W L., Palladino M A., et al. Interleukin 8 in rheumatoid and osteoarthritis. Scand J Rheumatol 1992; 21: 92–4